» Articles » PMID: 21356739

Bone Marrow-Derived Macrophages (BMM): Isolation and Applications

Overview
Journal CSH Protoc
Date 2011 Mar 2
PMID 21356739
Citations 506
Authors
Affiliations
Soon will be listed here.
Abstract

INTRODUCTIONBone marrow-derived macrophages (BMM) are primary macrophage cells, derived from bone marrow cells in vitro in the presence of growth factors. Macrophage colony-stimulating factor (M-CSF) is a lineage-specific growth factor that is responsible for the proliferation and differentiation of committed myeloid progenitors into cells of the macrophage/monocyte lineage. Mice lacking functional M-CSF are deficient in macrophages and osteoclasts and suffer from osteopetrosis. In this protocol, bone marrow cells are grown in culture dishes in the presence of M-CSF, which is secreted by L929 cells and is used in the form of L929-conditioned medium. Under these conditions, the bone marrow monocyte/macrophage progenitors will proliferate and differentiate into a homogenous population of mature BMMs. The efficiency of the differentiation is assessed using fluorescence-activated cell sorting (FACS) analysis of Mac-1 and 4/80 surface antigen expression. Once differentiated, the BMMs are suitable for numerous types of experimental manipulations, including morphological, gene expression, and physiological studies. For example, phagocytic cells such as macrophages have a unique ability to ingest microbes. We describe a test for the phagocytic efficiency of BMMs by exposing them to fluorescently labeled yeast zymosan bioparticles. Also, a method to deliver DNA or small interfering RNAs (siRNAs) into these hard-to-transfect cells is described. Finally, the proliferation of the BMMs is assayed using carboxyfluorescein succinimidyl ester (CFSE), a fluorescein derivative that partitions equally between daughter cells after cell division.

Citing Articles

Promotion of NLRP3 autophagosome degradation by PV-K nanodevice for protection against macrophage pyroptosis-mediated lung injury.

Fan Y, Mei J, Shen Y, Gao Y, Zhao L, Meng S J Nanobiotechnology. 2025; 23(1):148.

PMID: 40016743 PMC: 11866711. DOI: 10.1186/s12951-025-03219-y.


CD47 prevents Rac-mediated phagocytosis through Vav1 dephosphorylation.

Miller W, Mishra A, Sheedy C, Bond A, Gardner B, Montell D bioRxiv. 2025; .

PMID: 39990418 PMC: 11844498. DOI: 10.1101/2025.02.11.637707.


Target cell adhesion limits macrophage phagocytosis and promotes trogocytosis.

Rollins K, Fiaz S, Morrissey M bioRxiv. 2025; .

PMID: 39975079 PMC: 11839035. DOI: 10.1101/2025.02.06.636906.


Unveiling the Phenotypic Variability of Macrophages: Insights from Donor Diversity and Pooling Strategies.

Taciak B, Grochowska A, Gorczak M, Gorka E, Skorzynski M, Bialasek M Int J Mol Sci. 2025; 26(3).

PMID: 39941039 PMC: 11818227. DOI: 10.3390/ijms26031272.


Naltriben promotes tumor growth by activating the TRPM7-mediated development of the anti-inflammatory M2 phenotype.

Nascimento Da Conceicao V, Sun Y, Venkatesan M, De La Chapa Chapa J, De La Chapa J, Ramachandran K NPJ Precis Oncol. 2025; 9(1):29.

PMID: 39875485 PMC: 11775176. DOI: 10.1038/s41698-025-00815-x.